4.7 Article

Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biology

Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review

Mariana Ulinici et al.

Summary: RT-PCR remains the gold standard for COVID-19 diagnosis, but more rapid or affordable testing options have been developed. Antigen testing, while less sensitive than molecular assays, may be preferable for wider screening initiatives. Simple parameters can facilitate prognostication and triage.

LIFE-BASEL (2021)

Editorial Material Infectious Diseases

SARS-CoV-2 rapid diagnostic tests for emerging variants

Meriem Bekliz et al.

LANCET MICROBE (2021)

Editorial Material Medicine, General & Internal

Genetic Variants of SARS-CoV-2-What Do They Mean?

Adam S. Lauring et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Michael A. Johansson et al.

Summary: The study suggests that more than half of COVID-19 transmission may come from asymptomatic individuals, highlighting the importance of measures beyond identifying and isolating symptomatic cases in controlling the spread of the virus.

JAMA NETWORK OPEN (2021)

Article Microbiology

Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting

Nkemakonam C. Okoye et al.

Summary: The performance of Abbott BinaxNOW COVID-19 antigen card was compared to a standard RT-PCR assay for detecting SARS-CoV-2 in asymptomatic students. Results showed lower sensitivity but higher specificity for BinaxNOW compared to RT-PCR, indicating caution is needed when using rapid antigen testing for screening asymptomatic individuals.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity

Rahul Subramanian et al.

Summary: The study suggests that asymptomatic infections play a significant role in the spread and resurgence of COVID-19, even though it is challenging to accurately estimate their contributions due to changes in testing capacity. Even if asymptomatic infections have lower transmission rates, they still comprise a substantial portion of the force of infection along with presymptomatic cases.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Virology

Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week

Paloma Troyano-Hernaez et al.

Summary: Monitoring the genetic diversity and mutations of SARS-CoV-2 is crucial for understanding its evolution and ensuring the effectiveness of diagnostic tests, vaccines, and therapies against COVID-19. This study analyzed over 100,000 worldwide SARS-CoV-2 sequences and found significant amino acid changes in the structural proteins, highlighting the importance of ongoing surveillance and research on emerging mutations.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection

Alvin Kuo Jing Teo et al.

Summary: The study found saliva to be a sensitive sample for COVID-19 diagnosis, with a higher positivity rate compared to nasopharyngeal and self-administered nasal swabs. Cycle threshold values were lower across all sample types during the early stage of infection.

SCIENTIFIC REPORTS (2021)

Article Biology

COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest

Albert Tian Chen et al.

Summary: COVID-19 CG is an open resource for tracking SARS-CoV-2 single-nucleotide variations, lineages, and clades using the GISAID database. Users can query SNVs across different regions, mutations impacting diagnostic sensitivity, and the emergence of dominant lineages. The platform will be upgraded with new features to rapidly pinpoint mutations as the virus evolves and in response to interventions.
Article Microbiology

Structure-guided antibody cocktail for prevention and treatment of COVID-19

Shih-Chieh Su et al.

Summary: The study developed a series of chimeric antibodies targeting the RBD of the SARS-CoV-2 spike protein, with some exhibiting exceptionally potent neutralizing activities. Cryo-electron microscopy analyses of two highly potent antibodies complexed with the SARS-CoV-2 spike protein suggested they may be particularly useful when combined in a cocktail therapy.

PLOS PATHOGENS (2021)

Review Infectious Diseases

Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as of November 20, 2020

Johannes Hayer et al.

Summary: This study conducted a systematic meta-analysis to compare the real-world performance of different commercially available RATs for diagnosing SARS-CoV-2 infection. It found that RATs offered by Roche Diagnostics/SD Biosensor and Abbott had the highest sensitivity and are recommended for detecting current SARS-CoV-2 infection, especially in high-viral-load populations.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Letter Medicine, General & Internal

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications

Salim S. Abdool Karim et al.

Summary: The emergence of SARS-CoV-2 variants, including B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351), and P.1 (B.1.1.28.1), has raised concerns about worsening Covid-19 and potential escape from vaccine-induced immunity.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Virology

Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2

Teodora Djukic et al.

Summary: A cost-effective method has been developed for production of a soluble recombinant fragment of the SARS-CoV-2 nucleocapsid protein, which showed reliable detection of IgG and IgM antibodies in SARS-CoV-2 infection diagnosis.

VIROLOGY (2021)

Article Multidisciplinary Sciences

The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA

Jasmine Cubuk et al.

Summary: The study reveals that SARS-CoV-2 nucleocapsid (N) protein undergoes liquid-liquid phase separation with RNA, and provides molecular details of N protein through single-molecule spectroscopy with all-atom simulations, showing its multivalent RNA-binding nature and interactions that may drive RNA compaction.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection

Dandan Shan et al.

Summary: The study introduces a highly sensitive Simoa immunoassay for detecting SARS-CoV-2 nucleocapsid protein in venous and dried capillary blood as well as saliva, showing good performance in symptomatic, asymptomatic, and pre-symptomatic PCR+ individuals.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation

Sisi Kang et al.

Summary: This study isolated and analyzed 32 N protein-specific monoclonal antibodies from a COVID-19 convalescent patient, shedding light on the response to the N protein. The complex structure of the mAb with the highest binding affinity revealed changes in epitopes and regulation of the antigen, affecting the N protein-induced complement hyperactivation.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage

Juan Ma et al.

Summary: The nucleocapsid of SARS-CoV-2 inhibits host pyroptosis by blocking Gasdermin D cleavage, while infected monocytes show enhanced IL-1 beta expression but reduced secretion.

EMBO JOURNAL (2021)

Letter Infectious Diseases

Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil

Vagner Fonseca et al.

JOURNAL OF INFECTION (2021)

Review Genetics & Heredity

The biological and clinical significance of emerging SARS-CoV-2 variants

Kaiming Tao et al.

Summary: The emergence of multiple SARS-CoV-2 variants has significant impacts on the epidemiological and clinical aspects of the COVID-19 pandemic, including increased virus transmission rates, heightened risk of reinfection, and reduced effectiveness of neutralizing antibodies and vaccines. These variants have introduced new challenges to COVID-19 research, necessitating additional avenues of laboratory, epidemiological, and clinical studies.

NATURE REVIEWS GENETICS (2021)

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care

Clemens Gutmann et al.

Summary: Prognostic characteristics for ICU COVID-19 patients can be determined using blood samples, with RNAemia and pentraxin-3 identified as predictors of 28-day ICU mortality. Additionally, galectin-3-binding protein is found to interact with the SARS-CoV-2 spike glycoprotein and exhibit antiviral properties.

NATURE COMMUNICATIONS (2021)

Article Medicine, General & Internal

Clinical assessment of the Roche SARS-CoV-2 rapid antigen test

Gian Luca Salvagno et al.

Summary: The study assessed the clinical performance of the Roche SARS-CoV-2 Rapid Antigen Test and found that it has excellent accuracy and sensitivity in nasopharyngeal swabs with Ct values <25, making it reliable for screening patients with high viral load. However, more sensitive techniques would be needed for mass community screening.

DIAGNOSIS (2021)

Article Immunology

Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands

Zsofia Igloi et al.

Summary: The Roche SD Biosensor rapid antigen test for SARS-CoV-2 demonstrated high sensitivity and specificity for detecting symptomatic individuals in the early phase of the disease, particularly those seeking care within 7 days of symptom onset. These rapid antigen tests could play a crucial role in identifying the most infectious persons and stopping the spread of SARS-CoV-2.

EMERGING INFECTIOUS DISEASES (2021)

Review Immunology

Neutralizing monoclonal antibodies for treatment of COVID-19

Peter C. Taylor et al.

Summary: The study discusses the clinical utility of neutralizing monoclonal antibody therapies targeting SARS-CoV-2, emphasizing the importance of patient stratification, biomarkers, risk factors, and other clinical considerations.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

Letter Medicine, General & Internal

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Lirong Zou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Microbiology

Laboratory Diagnosis of COVID-19: Current Issues and Challenges

Yi-Wei Tang et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Article Chemistry, Multidisciplinary

Assay Techniques and Test Development for COVID-19 Diagnosis

Linda J. Carter et al.

ACS CENTRAL SCIENCE (2020)

Editorial Material Biotechnology & Applied Microbiology

The COVID-19 vaccine development landscape

Tung Thanh Le et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Biochemistry & Molecular Biology

Biochemical characterization of SARS-CoV-2 nucleocapsid protein

Weihong Zeng et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Multidisciplinary Sciences

Molecular diagnostic technologies for COVID-19: Limitations and challenges

Adeel Afzal

JOURNAL OF ADVANCED RESEARCH (2020)

Review Biochemistry & Molecular Biology

Extrapulmonary manifestations of COVID-19

Aakriti Gupta et al.

NATURE MEDICINE (2020)

Article Cell Biology

COVID-19 diagnostics in context

Ralph Weissleder et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Review Cell Biology

Development of therapeutic antibodies for the treatment of diseases

Ruei-Min Lu et al.

JOURNAL OF BIOMEDICAL SCIENCE (2020)

Article Biochemistry & Molecular Biology

Antibody Recognition of Disordered Antigens

Christopher A. MacRaild et al.

STRUCTURE (2016)